Drug Control Policy: The European Perspective

DT
by David Timis2 views·Updated Nov 13, 2013
Powered by AI

Need to present on this topic?

Create your own polished presentation in minutes. Just describe what you need.

Free to try, no credit card required

Transcript

When you can stop you don't want to, and when you want to stop you can't...

Addiction is a complex disease, and quitting takes more than good intentions or a strong will.

In other words, addiction is here to stay.

The current economic crisis has precipitated an onset of new addiction challenges and there is a sense of concern that treatment and prevention programs will continue to be cut as countries look for ways to balance their budgets.

• an increased prevalence of HIV among Injected Drug Users (IDU’s) since the beginning of the economic crisis;

• increased waiting periods to have access to opioid substitution treatment due to the cuts made under austerity measures;

• reduced volume of injection equipment exchange due to the budget cuts made in several countries in Europe;

• an increasing concern amongst policy makers about the stigmatization of drug addiction and subsequent discrimination (“addict-o-phobia”).

The financial crisis that has engulfed Europe since 2008 has caused:

  • increases in national debt levels;
  • rising interest rates;
  • decreased GDP;
  • worsening unemployment rates.

The most vulnerable groups of people hit by the crisis are:

  • children;
  • old people;
  • people with disabilities;
  • migrants and refugees;
  • ethnic minorities;
  • low income people;
  • unemployed people.

The economic crisis leads to among others:

• widespread malnutrition;

• stunted growth in children;

• substance abuse, which in turn leads to:

  • HIV infections;
  • alcohol-related deaths;
  • suicides.

• increased susceptibility to disease.

Evidence suggests that the economic downturn, and particularly unemployment, has also a dramatic effect on mental health:

• The prevalence of psychological problems in unemployed people (34%) is more than twice than in employed people (16%);

• The negative effects of unemployment on mental health were less in countries with strong employment protection systems (Sweden, Finland) than in those with poor employment protection (Spain, Greece).

An HIV outbreak in injecting drug users that started in 2011, worsened in 2012 as a result of the economic crisis:

• Beginning with 2007 and up until 2010, between 10 and 15 HIV infections were reported yearly in injecting drug users in Greece.

• The number of infections increased to 256 in 2011, and to 314 in the first 8 months of 2012.

Low provision of preventive services has been an important contributor to increased HIV transmission in Greece, and non-governmental organizations reported disruptions of needle exchange programmes and other preventive initiatives since 2008.

However, despite more than 100 years of research about the effects of economic turbulence on health, the relation between the two is not yet fully understood.

This is due to several factors:

  • the absence of up-to-date morbidity and mortality data;
  • the lack of funding for health research;
  • the largely silent public health voices and health ministries.

Way Forward

On one hand, some countries were better prepared to face the crisis and they:

  • protected their health budgets by making cuts in other sectors;
  • increased taxes on alcohol and tobacco in order to raise revenue and promote health.

On the other hand, other countries were not prepared for the crisis and they:

  • cut costs, particularly in the hospital and pharmaceutical sectors;
  • reduced or froze the salaries of their health professionals.

The uncertainty created by the crisis and the consequences of austerity measures are not reassuring and they are not prefiguring any significant economic improvements in the near future.

An absence of economic growth means loss of income and employment, and reductions in social assistance for ordinary people, which have long-lasting consequences for the most vulnerable members of society.

However, a small source of optimism is that European civil society organizations, including professional bodies, have spoken out about the adverse health effects of cuts to health and social spending.

Recently, Nils Muiznieks, the Commissioner for Human Rights of the Council of Europe, said that in order to recover from the economic shock:

“We need to rethink our approach to the crisis, putting human rights at the center of our efforts to bring order and sustainability to our public finances”.

The question is whether anyone will listen…

THANK YOU FOR YOUR ATTENTION!

Drug Control Policy: The European Perspective

International Symposium

European University Institute

17-18 June 2013, Florence, Italy

Patrick Penninckx

Executive Secretary of the Pompidou Group

patrick.penninckx@coe.int

Responding to Drug Use in Europe's Prisons

The Web Revolution

People Who Inject Drugs

Patterns of Drug Use Are Shifting

Heroin Use in Decline

635 000 people are held in penal institutions in the EU, and most of them initiate drug use or begin to engage in more harmful practices while incarcerated; this is due to:

•overcrowding;

•poor hygiene;

•lack of healthcare provision.

Opioids other than heroin are now cited as the main problem drugs by a high proportion of those entering treatment:

  • synthetic opioid fentanyl (Estonia);
  • buprenorphine (France);
  • increased use of amphetamines (Hungary).

Heroin is still responsible for the largest share of drug-related diseases and deaths in the EU, but while these problems continue, they do so at lower levels:

• new recruitment into heroin use has fallen;

• the availability of the drug has declined;

• some countries have experienced acute shortages of heroin.

16 million people inject drugs globally, 3 million of whom are living with HIV.

Eastern Europe and Central Asia are the two regions vital to the success of reducing these figures by 2015.

Here, the number of people newly affected is rising, and the domestic public sector only provides 15% of spending on prevention programmes for people who inject drugs.

New drugs are invented every year to circumvent current bans, and freely sold on the internet; as consequences:

  • people are taking more drugs than the authorities even know exist;
  • new designer drugs are created by slightly altering the formula for known molecules such as MDMA or LSD;
  • when the new drugs are banned, users simply start experimenting with other dangerous chemicals.

Financial Crisis in Europe

Who are we?

  • An intergovernmental body formed in 1971 at the suggestion of the French President Georges Pompidou.
  • Began as an informal co-operation forum of 7 European countries (France, Belgium, Germany, Italy, Luxembourg, Netherlands, United Kingdom) looking to share their experience with combating drug abuse and drug trafficking.
  • Incorporated into the Council of Europe in 1980.
  • At present, the Pompidou Group comprises 35 member states.

Consequences on Public Health

How do we do it?

What do we do?

  • contribute to the development of multidisciplinary, innovative, effective and “evidence-based” drug policies in 35 member states.
  • seek to link policy, practice and science.
  • play a bridging role between EU countries and non-EU countries.
  • cooperate with other Council of Europe initiatives, placing special emphasis on ethical issues and respect of human rights.

HIV Outbreak in Greece

Currently, the Pompidou Group carries out activities in the following areas:

  • Airports - Reducing drug supply and drug trafficking
  • EXASS Net - Drug policy co-operation in South-East Europe and the Balkans
  • MedNET - Activities within the Mediterranean network
  • Fight against Chemical Precursor Diversion
  • Prevention at work
  • Prevention in prisons
  • Research
  • Treatment

Pompidou Group's Response

European countries' response

Several European countries have requested the Pompidou Group to take urgent actions to address the issue of reduced budgetary resources for drug policy programmes and the public health consequences resulted from the crisis.

After the fall of GDP and tax revenues, and the increase in unemployment and spending, European countries had responded to the financial crisis in various ways:

Aims and Objectives

• to analyze the possible consequences resulting from the economic crisis in Europe for drug use patterns and resulting adverse social and public health effects;

• to identify drug policy responses to contain adverse social and public health consequences related to drug use and risk taking behavior in times of economic crisis;

• to provide guidance to governments when setting drug policy priorities under conditions of austerity budgets;

• to propose a mechanism for on-going consultation, sharing of experiences and mutual support for drug policy decision makers from concerned and interested countries.

Recent Developments Concerning the Spread of IDU's and HIV

Austerity Measures

Recent Projects

  • An "International Conference on Mental Health and Addiction in Prisons" was organized in Bucharest Romania, in February, 2013;
  • A workshop on "Pharmacotherapy with Methadone" was organized in Chisinau, Moldavia, in April 2013;
  • In Morocco, addictology courses are currently on-going in two universities (Rabat and Casablanca);
  • In Egypt, the project concerning the "Gender Oriented Care of Substance Dependent Women" is preparing a workshop for the 15 of May, in Cairo.
  • The austerity policies have been very controversial, because recent evidence has shown that they have affected economic growth much more adversely than previously believed.
  • Moreover, austerity affects all sectors of government spending, including public health and drug policies. One of the consequences is a decreased extent of coverage for health and prevention services, including harm reduction and substitution treatment programmes.

Future Recovery

patrick.penninckx@coe.int http://www.coe.int/pompidou